A 64-year-old retired teacher arrived at ValorSpine with a post-fall L4-L5 disc protrusion, prior lumbar osteoarthritis, and a surgical recommendation for fusion. Through staged non-surgical care anchored in non-surgical spine treatment, she returned to gardening and grandchild care without surgery, with VAS pain falling from 78 mm to 22 mm over 18 months.
Case Summary
| Field | Detail |
|---|---|
| Patient archetype | 64-year-old retired elementary school teacher, post-fall lumbar injury |
| Diagnosis | L4-L5 disc protrusion with annular tear; preexisting facet osteoarthritis |
| Mechanism | Fall down four wooden porch steps onto her lower back |
| Surgical recommendation | L4-L5 instrumented fusion (declined) |
| Approach used | Staged conservative care, targeted decompression, intra-annular fibrin injection |
| Primary outcomes | VAS 78 → 22 mm; ODI 52% → 14%; opioid-free at 16 weeks |
| Follow-up window | 18 months |
This case study is part of our broader work on spinal fusion alternatives and reflects the staged decision framework we use for every post-fall lumbar injury in adults over 60. For the full conservative-first roadmap, see how to avoid spinal fusion surgery.
Context and Baseline
The patient is a retired public school teacher who lives independently with her husband. She fell down four porch steps in early winter, landing on her sacrum and lower lumbar spine. She walked away from the fall, applied ice, and assumed the pain would resolve. Six weeks later, the pain had migrated into her right buttock and posterior thigh, and she had begun limiting her morning walks, garden work, and trips to see her grandchildren.
Her primary care physician ordered lumbar MRI imaging. The study showed a focal L4-L5 disc protrusion contacting the right traversing L5 nerve root, an annular fissure at the same level, multilevel facet hypertrophy consistent with age-related osteoarthritis, and mild central canal narrowing. There was no fracture, no instability on flexion-extension radiographs, and no progressive neurological deficit.
Baseline measurements at intake:
- Visual Analog Scale (VAS) pain score: 78 mm out of 100
- Oswestry Disability Index (ODI): 52% (severe disability range)
- Standing tolerance: under 10 minutes before forced sitting
- Walking tolerance: 5–7 minutes before right-leg radiation forced rest
- Sleep: waking 3–4 times per night with positional pain
- Medication: scheduled acetaminophen, intermittent oxycodone, gabapentin 300 mg three times daily
A regional spine surgeon reviewed the imaging and recommended L4-L5 instrumented fusion, citing her age, the fall mechanism, the disc protrusion, and the underlying osteoarthritis. She came to ValorSpine for a second opinion specifically because she did not want fusion. Her concerns mirrored what the literature confirms: roughly 40% of back surgeries do not achieve the patient’s desired outcome, and average recovery from spinal fusion runs 3–6 months or longer. She wanted to know whether her injury truly required hardware.
Approach
Our clinical reading of her case was that the fall had aggravated a pre-existing degenerative segment but had not produced the kind of structural damage that mandates fusion. There was no instability, no progressive weakness, no cauda equina signs, and no failed prior conservative trial. We built a staged plan with four objectives, in order: calm the inflammatory phase, restore neural mobility, repair the annular tear biologically, and rebuild capacity in the surrounding musculature.
The plan was deliberately sequenced rather than simultaneous. Stacking every modality at once obscures which intervention is actually moving the needle and burns through the patient’s time, money, and patience. Staging also lets the body respond before we add the next input.
Stage 1 — Inflammatory control and neural desensitization (weeks 0–6). Activity modification, lumbar-specific physical therapy focused on directional preference and nerve glides, mechanical traction trials, and a single transforaminal epidural steroid injection at right L4-L5. The injection was used as a diagnostic-therapeutic test, not as a long-term solution. The AAFP systematic review classifies epidural steroids as not effective for chronic low back pain alone, but they remain useful for acute radicular flares to enable rehabilitation.
Stage 2 — Targeted decompression and motor control (weeks 6–14). Non-surgical spinal decompression at L4-L5 (20 sessions), continued physical therapy with a shift to hip and core endurance work, and structured daily walking. Spinal decompression produces sustained improvement in roughly 36.8% of patients at 6 months in published cohorts, which made it a reasonable adjunct given her favorable response to manual traction in Stage 1.
Stage 3 — Biologic disc repair (week 16). Intra-annular fibrin injection at L4-L5 to address the annular fissure directly. Published cohort data on intra-annular fibrin injection shows VAS scores moving from 72.4 mm at baseline to 33.0 mm at 104 weeks, with 70% patient satisfaction at 2-plus year follow-up and 80% positive outcomes among failed-back-surgery patients. The procedure addresses the structural defect rather than masking the symptom.
Stage 4 — Capacity rebuilding (weeks 18–52). Progressive resistance training, balance and fall-prevention work, and a return-to-activity ladder built around her actual goals: gardening, lifting grandchildren, and overnight travel.
Implementation
Compliance was the single largest determinant of how this case unfolded. The patient kept a paper log of pain scores, walking minutes, and sleep quality. We reviewed the log at every visit and used it to decide whether to advance, hold, or step back. This is the same approach we describe in our non-surgical spine recovery case study, and it consistently outperforms unstructured care.
Weeks 0–6. Physical therapy three times per week with home exercises twice daily. The transforaminal epidural at the end of week 2 dropped right-leg radiation by roughly 60% within 72 hours, which opened a window for active rehabilitation. By week 6, walking tolerance was 22 minutes and gabapentin had been tapered to 300 mg twice daily.
Weeks 6–14. Spinal decompression sessions ran three times per week, tapering to twice per week by week 10. Physical therapy continued at twice per week with progressive hip-hinge mechanics, dead-bug variations, and side-plank progressions. Oxycodone was discontinued in week 8. By week 14, VAS had dropped to 38 mm and ODI to 28%.
Week 16. Intra-annular fibrin injection at L4-L5 under fluoroscopic guidance. The patient experienced an expected 7–10 day post-procedure flare, then a steady downward trajectory in pain and a noticeable improvement in morning stiffness.
Weeks 18–52. Progressive strength training with a clinical exercise physiologist twice weekly. Gabapentin was discontinued at week 24. Acetaminophen became as-needed only at week 32. By week 40, she had returned to morning gardening and was lifting her 32-pound granddaughter without guarding.
For readers comparing approaches across different patient profiles, our trail runner L5-S1 annular tear case study and veteran low back non-surgical case study show how the same staged framework adapts to younger patients and to service-connected mechanisms of injury.
Results
| Metric | Baseline | Week 14 | Week 52 | Month 18 |
|---|---|---|---|---|
| VAS pain (mm) | 78 | 38 | 26 | 22 |
| Oswestry Disability Index | 52% | 28% | 16% | 14% |
| Walking tolerance | 5–7 min | 22 min | 55 min | 60+ min |
| Standing tolerance | <10 min | 25 min | 50 min | 60+ min |
| Opioid use | Daily PRN | None | None | None |
| Gabapentin | 900 mg/day | 600 mg/day | None | None |
| Nighttime awakenings | 3–4 | 1–2 | 0–1 | 0–1 |
Two findings stand out. First, the largest single jump in function came not from the fibrin injection itself but from the combination of inflammatory control plus targeted decompression in Stages 1 and 2. The injection delivered the durable, structural improvement that locked in those gains. Second, the osteoarthritis component never required direct intervention. Once the disc and the surrounding soft tissue settled, the facet joints stopped driving symptoms. This is consistent with what we see across this patient archetype: the fall is the trigger, the disc is the structural lesion, and the osteoarthritis is the background condition that the surgical opinion overweights.
She remains opioid-free, gabapentin-free, and surgery-free at the 18-month follow-up. Her ODI of 14% places her in the minimal-disability range. She has resumed every activity she listed as a goal at intake.
Lessons Learned
Age and osteoarthritis are not, by themselves, indications for fusion. The fusion recommendation in this case rested heavily on background degeneration that was present before the fall and that was not symptomatic before the fall. A staged conservative trial answered the question that imaging alone cannot: how much of the pain is coming from the new structural injury versus the old degenerative changes. In this patient, the answer was clear once the disc settled.
Sequencing beats stacking. Running every modality in parallel makes outcomes harder to interpret and harder to defend. Sequenced care builds a clear evidentiary record of what worked, which matters when patients face surgical pressure from family or other clinicians.
Patient logs change clinical decisions. Daily pain and function logs surfaced a plateau at week 12 that we would have missed otherwise, and that plateau is what triggered the move to Stage 3 on schedule rather than waiting another 4–6 weeks.
Transparency: What We Would Do Differently
Two adjustments would improve this protocol on a similar future case. First, we would start the clinical exercise physiology referral at week 8 rather than week 18. The motor-control work in Stages 1 and 2 was adequate, but earlier introduction of progressive resistance training would likely shorten the total recovery timeline by 8–12 weeks. Second, we would forego the transforaminal epidural and rely on oral anti-inflammatories plus aggressive directional-preference therapy in Stage 1. The injection helped, but the AAFP review and our own outcomes data suggest the marginal benefit is small enough that we should reserve injections for patients who fail the first 2–3 weeks of active care.
One outcome we cannot generalize from this case: the speed of the response to spinal decompression. She responded faster than the published 36.8% sustained-improvement rate would predict. Whether that reflects patient selection, the staged sequencing, or random variation is unclear from a single case.
Frequently Asked Questions
Can a 60-something patient with a post-fall lumbar disc protrusion really avoid fusion?
Yes, in the absence of progressive neurological deficit, instability, or cauda equina syndrome, most post-fall lumbar disc protrusions in this age group respond to staged conservative care. Nearly 1 in 5 patients told they need spine surgery choose not to have it, and outcomes data on conservative pathways for radicular pain support that decision in appropriately selected patients. Surgical urgency is a function of the neurological exam and structural stability, not age alone.
Does pre-existing lumbar osteoarthritis change the treatment plan?
It changes how we interpret imaging, not how we sequence treatment. Facet osteoarthritis is present in the majority of adults over 60 and does not, by itself, generate the kind of acute radicular pain that follows a fall. We treat the new structural lesion, document the response, and revisit the osteoarthritis only if symptoms persist after the disc and soft tissue settle.
How long does staged non-surgical care for a post-fall lumbar injury take?
Plan on 4–6 months for the active treatment phases and another 6–12 months for capacity rebuilding and durable functional gains. This case ran 18 months from intake to the final follow-up reported here. Compared to the 3–6 months of recovery typically quoted for spinal fusion plus the risk of failed back surgery syndrome, the timeline is competitive and the risk profile is lower.
What is intra-annular fibrin injection and why was it used here?
Intra-annular fibrin injection is a biologic disc repair technique that delivers a fibrin sealant into an annular tear to address the structural defect at the source. Cohort data shows VAS pain scores dropping from 72.4 mm to 33.0 mm at 104 weeks, with 70% patient satisfaction at 2-plus year follow-up. In this case, it was used after Stages 1 and 2 had calmed the inflammatory and neural components but had not fully resolved the underlying tear.
How do I know if my own situation is a candidate for this kind of staged care?
The honest answer is that imaging alone cannot tell you. The decision rests on the neurological exam, structural stability on dynamic imaging, the absence of red-flag findings, and a careful inventory of what conservative care has actually been tried at adequate dose and duration. A second opinion focused on those criteria, rather than on the imaging report, is the right starting point.
Sources and Further Reading
- American Academy of Family Physicians — systematic review on epidural steroid injections for chronic low back pain
- National Institute of Neurological Disorders and Stroke — background on lumbar disc disorders and conservative management
- Peer-reviewed cohort literature on intra-annular fibrin injection — VAS and satisfaction outcomes at 104-week follow-up
- Published cohort data on non-surgical spinal decompression — sustained improvement rates at 6 months
- Journal of Neurosurgery — outcome data on lumbar fusion, including failed back surgery syndrome and revision rates
- U.S. Department of Veterans Affairs — background on lumbar pain epidemiology and conservative care pathways
Next Step
Ready to explore non-surgical options for your back pain? Schedule your consultation with ValorSpine today.
